IMMULITE 2000 Free PSA
Siemens Medical Solutions Diagnostics Limited · Decision date Oct 30, 2025
What did the FDA decide?
FDA records P060005/S023 as a supplement to PMA P060005, with the supplement type “30-Day Notice”. The recorded decision is OK30 (30-day notice), dated Oct 30, 2025.
FDA approval order statement
Approval for the move of critical raw material operations of an internal supplier in-house to an internal company site.
- Regulatory pathway
- PMA supplement
- Supplement type
- 30-Day Notice
- Clinical specialty
- Immunology
- Decision date
- Oct 30, 2025
- FDA change category
- Process Change - Manufacturer/Sterilizer/Packager/Supplier
Regulatory record facts
- Identifier
- P060005/S023
- Regulatory pathway
- PMA supplement
- Product code
- MTG
- Decision code
- OK30
- Decision date
- Oct 30, 2025
- Source update
- Nov 9, 2026
- Original record
- Open FDA source record
About this medical device
FDA device category: Test, prostate specific antigen, free, (noncomplexed) to distinguish prostate cancer from benign conditions.
- Product code
- MTG
- FDA device class
- 3
For the original device and its historical approval scope, see PMA P060005. Subsequent supplements may change the device or its indications.
FDA decision timeline
P060005 · Original PMA
IMMULITE / IMMULITE 1000 AND IMMULITE 2000 FREE PSA ASSAYS
P060005/S022 · Related supplement
IMMULITE 2000 Systems Free Prostate-Specific Antigen (Free PSA)
P060005/S023 received
Application receipt date recorded by FDA.
P060005/S023 · FDA decision
30-Day Notice
P060005/S024 · Related supplement
IMMULITE 2000 Free PSA
P060005/S025 · Related supplement
IMMULITE 2000 Free PSA
P060005/S026 · Related supplement
IMMULITE Systems Free PSA
P060005/S027 · Related supplement
IMMULITE Systems Free PSA
Timeline entries are records held by MedtechLedger for P060005. View FDA’s full supplement list.
Related devices and submissions
Same PMA: P060005
| Product / regulatory record | Company | Pathway | Decision date | Source |
|---|---|---|---|---|
| Siemens Medical Solutions Diagnostics Limited | PMA approval | May 11, 2007 | FDA | |
| Siemens Medical Solutions Diagnostics Limited | PMA supplement | Aug 14, 2025 | FDA | |
IMMULITE 2000 Free PSAP060005/S024 | Siemens Medical Solutions Diagnostics Limited | PMA supplement | Apr 21, 2026 | FDA |
IMMULITE 2000 Free PSAP060005/S025 | Siemens Medical Solutions Diagnostics Limited | PMA supplement | Jul 27, 2026 | FDA |
IMMULITE Systems Free PSAP060005/S026 | Siemens Medical Solutions Diagnostics Limited | PMA supplement | Aug 20, 2026 | FDA |
IMMULITE Systems Free PSAP060005/S027 | Siemens Medical Solutions Diagnostics Limited | PMA supplement | Sep 22, 2026 | FDA |
Explore the linked device profile
Other records with product code MTG
| Product / regulatory record | Company | Pathway | Decision date | Source |
|---|---|---|---|---|
| Siemens Healthcare Diagnostics, Inc. | PMA approval | May 11, 2026 | FDA | |
| ABBOTT LABORATORIES | PMA supplement | Feb 12, 2026 | FDA | |
| Siemens Healthcare Diagnostics | PMA supplement | Jul 16, 2025 | FDA |
A shared product code identifies a classification relationship; it does not establish clinical equivalence.
Regulatory context
A PMA supplement records a change to a device with an existing premarket approval. The supplement’s approval applies to the change described in that submission.
Read our guide to FDA clearance and approval · FDA’s explanation of this pathway
Manufacturer intelligence
Siemens Medical Solutions Diagnostics Limited
- Headquarters
- Not reported
- Brand website
- Not reported
- FDA applicant address
- Glyn Rhonwy Llanberis, Caernarfon, Gwynedd Ll55, 4EL
Sources and methodology
- Original FDA record: P060005/S023
- openFDA source data · Source release Nov 9, 2026 · Retrieved Nov 20, 2026
FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.
How we use FDA records




